Chen Li Ye - Net Worth and Insider Trading
Chen Li Ye Net Worth
The estimated net worth of Chen Li Ye is at least $9 Million dollars as of 2025-04-25. Chen Li Ye is the senior management of Tibet Rhodiola Pharmaceutical Holding Co and owns about 246,446 shares of Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) stock worth over $9 Million. Details can be seen in Chen Li Ye's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Chen Li Ye has not made any transactions after 2008-01-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Chen Li Ye
Chen Li Ye Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Chen Li Ye owns 1 companies in total, including Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) .
Click here to see the complete history of Chen Li Ye’s form 4 insider trades.
Insider Ownership Summary of Chen Li Ye
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| SHSE:600211 | Tibet Rhodiola Pharmaceutical Holding Co | 2008-01-25 | senior management |
Chen Li Ye Latest Holdings Summary
Chen Li Ye currently owns a total of 1 stock. Chen Li Ye owns 246,446 shares of Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) as of January 25, 2008, with a value of $9 Million.
Latest Holdings of Chen Li Ye
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SHSE:600211 | Tibet Rhodiola Pharmaceutical Holding Co | 2008-01-25 | 246,446 | 36.51 | 8,997,743 |
Holding Weightings of Chen Li Ye
Chen Li Ye Form 4 Trading Tracker
According to the SEC Form 4 filings, Chen Li Ye has made a total of 0 transactions in Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) over the past 5 years. The most-recent trade in Tibet Rhodiola Pharmaceutical Holding Co is the sale of 246,446 shares on January 25, 2008, which brought Chen Li Ye around $685,913.
Insider Trading History of Chen Li Ye
- 1
Chen Li Ye Trading Performance
GuruFocus tracks the stock performance after each of Chen Li Ye's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Chen Li Ye is 14.49%. GuruFocus also compares Chen Li Ye's trading performance to market benchmark return within the same time period. The performance of stocks bought by Chen Li Ye within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Chen Li Ye's insider trading performs compared to the benchmark.
Performance of Chen Li Ye
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -5.24 | | | | | |
| Relative Return to S&P 500(%) | -4.91 | | | | | |
Chen Li Ye Ownership Network
Ownership Network List of Chen Li Ye
Ownership Network Relation of Chen Li Ye
Chen Li Ye Owned Company Details
What does Tibet Rhodiola Pharmaceutical Holding Co do?
Who are the key executives at Tibet Rhodiola Pharmaceutical Holding Co?
Chen Li Ye is the senior management of Tibet Rhodiola Pharmaceutical Holding Co. Other key executives at Tibet Rhodiola Pharmaceutical Holding Co include senior management Wang Bao Ming , senior management Cao Shu Zhen , and Supervisors Ren Bei Chen .
Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211)'s detailed insider trading history can be found in Insider Trading Tracker table.
Tibet Rhodiola Pharmaceutical Holding Co Insider Transactions
Chen Li Ye Mailing Address
Above is the net worth, insider trading, and ownership report for Chen Li Ye. Currently GuruFocus does not have mailing address information for Chen Li Ye.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
